Today’s AI Top Pick: TMDX

7/13/2026 · Highly Shorted Turnaround Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Turnaround Deep RotationTMDXBUY NOW8.7 / 107/13/2026

TMDX is the cleanest combination of screen-passing fundamentals AND a forecast tape that confirms without forcing me to chase. On fundamentals it's the standout: PE 16.35, fwdPe 21.69, ROE 45.22%, profit margin 27.04%, sales growth +30.24% YoY, EPS next year +70.83%, and analyst recom 1.64 with 63.2% target upside. This is a genuinely profitable medtech, not a lottery ticket — fundamental_score 6.75 sits near the top of the pool, and unlike PGY (fund_score 8) the tape isn't pinned at the top of range. Multi-timeframe alignment is strong and, importantly, NOT extended. The 1d forecast is huge (+50.09% short / +69.14% mid / +71.45% long), the 4h confirms (+5.94/+48.64/+42.59), the 1h is quietly positive (+3.01/+3.76/+0.30), and the weekly long term flips positive at +10.91% despite a brutal -50.85% 1wk drawdown. Position in range is a healthy 40.18% on the daily and 46.6% on 4h — middle of the range, not chasing a breakout. Bullish_prob 1.0, near_term_bullish 0.8. Contrast this with MNDY (95% pos on 1d, chasing), PGY (100% pos on 1wk with -58% forecasted decline long-term), or KVYO (95% pos on 1d) — all screen well but you'd be buying the top. News is the tiebreaker check: Evercore lowered PT to $90 but MAINTAINED Outperform; Motley Fool piece is a long-term bull case. No dilution, no legal overhang, no short-seller report — just target trim on a name already down 42.92% YoY. That's exactly the setup this screen is designed to find: hated (23.57% short float), beaten (-41.45% YTD), but earnings inflecting hard. Why today rather than wait: the 1h forecast is already turning green (+3.01% short) meaning the tape is stabilizing, drawdown from 21-bar high is only -1.9% on 1h and -9.39% on 1d — you're not catching a knife, you're catching a base. Waiting risks missing the +50% 1d short-term forecast move.

Entry zone

$69.50 - $72.50 (scale in around current $71.39; add on any dip to the 4h dd-from-high area near $68)

Stop loss

$63.50 (below the 4h -8.18% drawdown low, ~11% risk)

First target

$85 (matches 4h fc_mid +48.64% zone and prior consolidation)

Longer target

$105-$115 (aligns with 1d fc_long +71.45% and analyst target upside of 63.2%)

Risks

Short float 23.57% cuts both ways — can squeeze up but can also amplify downside on any earnings/guidance miss
Debt/Equity 1.75 is elevated for healthcare, limits flexibility if organ-transport volume growth stalls
Weekly timeframe still shows -50.85% drawdown from 21-bar high — trend hasn't confirmed reversal on higher timeframes yet
Evercore's PT cut to $90 (from higher) signals sell-side is still trimming; more cuts possible before Q2 print
fwdPe 21.69 vs trailing PE 16.35 means forward earnings estimates already price in growth — any deceleration hits multiple hard

Honorable mentions

QXOBest 'not-chasing' setup in the pool: pos_in_range 13.74% (1d) and 4.51% (1wk), 1d forecasts +14/+32/+29%, near_term_bullish 1.0, recom 1.14, EPS next Y +134.86%, RBC reiterates Outperform. Fundamentals weaker (negative margins during rollup phase) so #2 not #1.

CELHFund_score 6.5, PEG 0.81, sales +123% YoY, 1d fc +26.58/+56.56/+52.65%. Held back by Needham PT cut and 1h/4h short-term forecasts turning negative — needs a pullback to $28-29 for cleaner entry.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.7	Profitable medtech with 1d fc +50/+69/+71%, mid-range position (40%), and only a benign PT trim in the news.
2	QXO	BUY NOW	8.2	Deep-value rollup near range lows (1d pos 13.7%) with near_term_bullish 1.0 and RBC reiterating Outperform.
3	CELH	BUY PULLBACK	7.6	Strong 1d forecast +56% mid but 1h/4h shorts fading; wait for $28-29 retest.
4	PGY	BUY PULLBACK	7.2	Best fundamentals (fund_score 8, PEG 0.21) but 1wk pos_in_range 100% and 1wk fc -58% long — chasing risk.
5	CWH	BUY PULLBACK	6.9	Massive 1wk fc +190% and pos_in_range near 0, but debtEq 19.03 and negative StockStory coverage argue for smaller size.
6	PSIX	BUY PULLBACK	6.7	Fund_score 7.5 with 1d fc +80/+98/+101% but 1wk fc negative -37% — mixed timeframe signal.
7	MNDY	BUY PULLBACK	6.5	1d fc +60% and 1wk fc +147% but pos_in_range 95% on 1d — extended, wait for pullback.
8	KVYO	BUY PULLBACK	6.3	Near_term_bullish 1.0 and 1d fc +35% but pos_in_range 95% — chasing.
9	EYE	BUY PULLBACK	6.0	Solid 1d fc +23% mid with insider buying catalyst but pos_in_range 88.56% on 1d.
10	TTAN	WAIT	5.5	1d fc +24% but bullish_prob null and 1h/4h forecasts negative -11 to -15%.
11	WING	BUY PULLBACK	5.3	1d fc +60% long but pos_in_range 0 on 1h/4h — knife-catching risk without base.
12	PROP	WAIT	5.1	4h fc +104% but debtEq 1222 and roe -700%; too levered for full size.
13	MBRX	WAIT	5.0	1wk fc +68% and near_term 1.0 but MIRACLE data called 'not significant' by Stocktwits — thesis fragile.
14	PCT	WAIT	4.9	Near_term 1.0 and 1d fc +50% long but P/S 132.9 and gross margin -1124% is a red-flag valuation.
15	UPXI	WAIT	4.7	1wk fc +900% long is an outlier; Cantor just cut PT — treat as speculation only.
16	ASST	WAIT	4.5	Bitcoin proxy with 1h fc +34% long but P/S 178 and profit margin -12110% is a bet on BTC, not the business.
17	GTBP	WAIT	4.3	597.7% target upside but 1h/1d pos_in_range near 10% with roe -1446% and $18.85M cap — lottery ticket.
18	DFDV	AVOID	4.2	1wk fc -47% long and pos_in_range 9% — deteriorating tape despite Cantor Overweight.
19	DVLT	WAIT	4.0	1d fc +107% long but only 2 timeframes available and USPTO 'anti-short' patent is a meme catalyst.
20	SPRY	WAIT	3.9	1wk fc +42% long but CEO just resigned and dropped from Russell 2000 defensive indices.
21	PDYN	WAIT	3.8	1d fc +40% short but 1wk fc -30% long and P/S 35.28 — mixed signals.
22	CRWV	WAIT	3.7	Only 3 timeframes, bullish_prob null, and recom 1.9 is weakest signal in the group.
23	SAIL	WAIT	3.6	1d fc +43% long but insider selling flagged by MarketBeat and bullish_prob null.
24	KULR	WAIT	3.4	1wk fc +50% but 1d fc negative and paused ATM offering suggests dilution overhang.
25	SAFX	AVOID	3.2	Pos_in_range 100% on 4h/1d and 1h fc -25% long — extended and forecast rolling over.
26	FLWS	WAIT	3.0	1wk fc +46% long but pos_in_range 100% on 1h and sales -9.53% YoY — declining fundamentals.
27	AIM	AVOID	2.5	1wk fc +4184% is a nonsense outlier from a $7.85M cap name with -74.93% YTD — untradeable.
28	CTXR	AVOID	2.3	No tape data in the multi-timeframe block and $16M cap — too illiquid.
29	RDW	AVOID	2.0	Bullish_prob 0.2, near_term 0, 1d fc negative, and Motley Fool asking if you should buy after 61% crash — broken.
30	MNTN	AVOID	1.8	Expected return -7.87%, bullish_prob null, and Simply Wall St just cut fair value — no edge.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord